Shanghai Cell Therapy Group Co.
Latest round
- Series D
Last raised
- Mar 2021
Total raised
- $279M
Investors
- 8
About Shanghai Cell Therapy Group Co.
, Ltd., Ltd. specializes in cellular medical health solutions. The company was founded by Jiewei Li, who has a background in cellular therapy innovations. Shanghai Cell Therapy Group is recognized as the first and only company in China to cover the entire value chain of cellular medical health. Their core offerings include advanced cellular rejuvenation products and therapies aimed at enhancing the quality of human life and contributing to longevity. By leveraging breakthroughs in cellular therapy technologies, they develop transformative solutions for curing cancers and age-related diseases.Shanghai Cell Therapy Group generates revenue through structured B2B partnerships with healthcare institutions and clinics. Their revenue streams are derived from the sale of cellular rejuvenation therapies and innovative treatment solutions, with contracts established directly with healthcare providers who incorporate these advanced products into their treatment offerings., Ltd. plans to accelerate its product research and development. The company is focused on designing new cellular therapies aimed at expanding their treatment solutions. Additionally, there are plans to explore international markets to broaden their reach beyond China, targeting specific regions yet to be disclosed. This strategic approach aims to enhance their standing in the global cellular therapy market.
Who invested in Shanghai Cell Therapy Group Co.
8 investors across 4 rounds
See all investors in Shanghai Cell Therapy Group Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Cell Therapy Group Co.
Who invested in Shanghai Cell Therapy Group Co.?
Shanghai Cell Therapy Group Co. has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Cell Therapy Group Co. raised?
Shanghai Cell Therapy Group Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Cell Therapy Group Co. last raise money?
Shanghai Cell Therapy Group Co.'s most recent round on record is a Series D, in Mar 2021.
What does Shanghai Cell Therapy Group Co. do?
Shanghai Cell Therapy Group Co. is a healthcare company.
Where is Shanghai Cell Therapy Group Co. headquartered?
Shanghai Cell Therapy Group Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Cell Therapy Group Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Shanghai Cell Therapy Group Co.'s stage. Their profiles are linked below.
VCs backing healthcare startups at Series D
Raising like Shanghai Cell Therapy Group Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.